Sign In
Buy EVOK
$11.00
+0 (+0%)
At Close: Mar 16, 2026
Evoke Pharma Completes Manufacturing of Commercial Scale Registration Batches of Gimoti™
12:30pm, Tuesday, 17'th Sep 2019
Evoke Pharma, Inc. (EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has completed manufacturing commercial scale batches of
Evoke Pharma Reports Completion Of Manufacturing Of Commercial-Scale Registration Batches Of Gimoti
12:00am, Tuesday, 17'th Sep 201918 Healthcare Stocks Moving In Friday's Pre-Market Session
12:43pm, Friday, 30'th Aug 2019Evoke Pharma to Resubmit Gimoti™ NDA Based on FDA Meeting Minutes and Announces Second Quarter 2019 Financial Results
09:30am, Thursday, 08'th Aug 2019
SOLANA BEACH, Calif., Aug. 08, 2019 -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today.
25 Healthcare Stocks Moving In Today's Pre-Market Session
12:00am, Thursday, 08'th Aug 201928 Healthcare Stocks Moving In Wednesday's After-Market Session
12:00am, Thursday, 01'st Aug 201928 Healthcare Stocks Moving In Today's Pre-Market Session
12:00am, Wednesday, 31'st Jul 201945 Healthcare Stocks Moving In Monday's After-Market Session
12:00am, Tuesday, 30'th Jul 201930 Healthcare Stocks Moving In Thursday's After-Market Session
12:00am, Friday, 26'th Jul 2019Biotech Stock On The Radar: Evoke Pharma Sets Date With FDA
04:58pm, Thursday, 25'th Jul 2019
After wallowing in penny stock territory until mid-July, the stock has broken the downtrend seen since early March and is experiencing some upward momentum. The company bought the rights to the inves
Biotech Stock On The Radar: Evoke Pharma Sets Date With FDA
12:00am, Thursday, 25'th Jul 2019Is Evoke Pharma, Inc. (NASDAQ:EVOK) A Volatile Stock?
03:31pm, Thursday, 11'th Jul 2019
If you're interested in Evoke Pharma, Inc. (NASDAQ:EVOK), then you might want to consider its beta (a measure of share...
Evoke Pharma Requests Type A FDA Meeting to Plan for Resubmission of Gimoti™ NDA
12:30pm, Thursday, 27'th Jun 2019
Evoke Pharma, Inc. (EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced that it has submitted a type A meeting request and meeting packa
